|
精優藥業控股有限公司, 00858.HK - 綜合損益表 |
2024-03 |
2023-03 |
2022-03 |
2021-03 |
2020-03 |
2019-03 |
2018-03 |
2017-03 |
2016-03 |
2015-03 |
2014-03 |
2013-03 |
2012-03 |
2011-03 |
2010-03 |
2009-03 |
2008-03 |
2007-03 |
2006-03 |
2005-03 |
營業額 |
59,098 |
72,577 |
73,925 |
78,802 |
77,584 |
89,218 |
85,762 |
107,903 |
142,201 |
128,833 |
150,673 |
151,068 |
157,406 |
198,816 |
196,291 |
184,434 |
165,079 |
158,763 |
178,265 |
169,766 |
經營溢利 |
-157,234 |
134,750 |
135,983 |
-116,784 |
88,656 |
64,282 |
29,185 |
21,824 |
29,090 |
-50,612 |
37,349 |
8,886 |
8,479 |
9,385 |
12,788 |
7,991 |
2,557 |
9,303 |
6,697 |
-87,835 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-4,282 |
0 |
-2 |
-164 |
0 |
0 |
0 |
聯營公司 |
-2,275 |
-3,849 |
-3,653 |
-2,879 |
-3,165 |
-908 |
1 |
-2,897 |
-1,600 |
-1,534 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
除稅前經營溢利 |
-159,509 |
130,901 |
132,330 |
-119,663 |
85,491 |
63,374 |
29,186 |
18,927 |
27,490 |
-52,146 |
37,349 |
8,886 |
16,863 |
5,103 |
12,788 |
7,989 |
2,393 |
9,303 |
6,697 |
-87,835 |
稅項 |
2,131 |
1,128 |
1,239 |
0 |
-90 |
50 |
-86 |
616 |
90 |
92 |
20,574 |
706 |
926 |
1,055 |
-2,784 |
-9,418 |
15,728 |
369 |
2,510 |
-1,793 |
少數股東權益 |
1,309 |
508 |
503 |
1,435 |
2,301 |
-706 |
0 |
-2,485 |
-5,839 |
-10,152 |
-344 |
-2,696 |
-4,477 |
-7,519 |
948 |
1,856 |
-1,600 |
-402 |
-482 |
-10,219 |
股東應占溢利 |
-162,949 |
129,265 |
130,588 |
-121,098 |
83,280 |
64,030 |
29,272 |
20,796 |
33,239 |
565,457 |
13,816 |
10,876 |
20,414 |
11,567 |
14,624 |
15,551 |
-11,735 |
9,336 |
4,669 |
-75,823 |
貨幣 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
9,045 |
8,797 |
8,727 |
8,124 |
6,361 |
6,296 |
6,387 |
6,486 |
6,294 |
6,029 |
2,940 |
3,089 |
4,066 |
3,018 |
4,626 |
5,094 |
4,681 |
4,539 |
4,530 |
6,396 |
利息 |
18,801 |
15,636 |
13,229 |
11,242 |
9,348 |
7,823 |
6,590 |
5,552 |
4,688 |
3,938 |
2,424 |
0 |
0 |
0 |
0 |
2 |
0 |
197 |
908 |
2,203 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
-1.34 |
0.86 |
0.94 |
|
-0.11 |
0.08 |
-0.29 |
3.25 |
0.33 |
-0.18 |
55.09 |
7.95 |
5.49 |
20.67 |
|
|
657.25 |
3.97 |
37.48 |
|
營業額增長(%) |
-18.57 |
-1.82 |
-6.19 |
1.57 |
-13.04 |
4.03 |
-20.52 |
-24.12 |
10.38 |
-14.49 |
-0.26 |
-4.03 |
-20.83 |
1.29 |
6.43 |
11.72 |
3.98 |
-10.94 |
5.01 |
-21.27 |
股東應占溢利增長(%) |
0.0 |
-1.01 |
0.0 |
0.0 |
30.06 |
118.74 |
40.76 |
-37.43 |
-94.12 |
3990.0 |
27.03 |
-46.72 |
76.48 |
-20.9 |
-5.96 |
|
|
99.96 |
|
|
核數師意見 |
0 |
1 |
1 |
1 |
2 |
2 |
2 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
1 |
2 |
2 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|